Direct-to-consumer (DTC) genetic tests promise to revolutionize the global consumer healthcare market by identifying serious illnesses before they arise, thus preventing the need to take medicines in the first place.
By asking consumers to collect their own DNA samples at home and send them via the post, for example, companies such as 23andMe claim to predict the likelihood of developing health
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?